glycine has been researched along with Leukemia L 1210 in 25 studies
Excerpt | Relevance | Reference |
---|---|---|
" The bioavailability of UK-21 given p." | 1.28 | Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25. ( Kato, T; Kitaichi, K; Koda, A; Mori, H; Sakamoto, O, 1992) |
"Forphenicinol (FPL) is a low molecular immunomodifier derived from forphenicine, a microbial product found by Umezawa and co-workers." | 1.27 | Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. ( Nitta, K; Takeuchi, M; Tanaka, T, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (92.00) | 18.7374 |
1990's | 2 (8.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosowsky, A | 1 |
Forsch, R | 1 |
BENNETT, LL | 2 |
SIMPSON, L | 1 |
GOLDEN, J | 1 |
BARKER, TL | 1 |
BROCKMAN, RW | 2 |
CHUMLEY, S | 1 |
Smithers, D | 1 |
Rose, LM | 1 |
Adamson, DJ | 1 |
Ishizuka, M | 2 |
Masuda, T | 1 |
Kanbayashi, N | 1 |
Watanabe, Y | 1 |
Matsuzaki, M | 1 |
Sawazaki, Y | 1 |
Ohkura, A | 1 |
Takeuchi, T | 2 |
Umezawa, H | 3 |
Rosenfeld, H | 1 |
Roberts, J | 1 |
Loh, E | 1 |
Kufe, DW | 1 |
Nagata, Y | 1 |
Takata, J | 1 |
Karube, Y | 1 |
Matsushima, Y | 1 |
Neil, GL | 2 |
Berger, AE | 2 |
McPartland, RP | 1 |
Grindey, GB | 2 |
Bloch, A | 1 |
Holcenberg, JS | 1 |
Uren, JR | 1 |
Ragin, R | 1 |
Chaykovsky, M | 1 |
Bhuyan, BK | 1 |
Blowers, CL | 1 |
Kuentzel, SL | 1 |
Lowe, JK | 1 |
Divekar, AY | 1 |
Hakala, MT | 1 |
Cysyk, RL | 1 |
Adamson, RH | 1 |
Sakamoto, O | 1 |
Mori, H | 1 |
Kitaichi, K | 1 |
Koda, A | 1 |
Kato, T | 1 |
Beardsley, GP | 1 |
Moroson, BA | 1 |
Taylor, EC | 1 |
Moran, RG | 1 |
Nitta, K | 2 |
Tanaka, T | 2 |
Okura, A | 1 |
Arakawa, H | 1 |
Yoshinari, T | 1 |
Naito, K | 1 |
Takeuchi, M | 1 |
Jackson, RC | 1 |
Harrap, KR | 1 |
Bell, JP | 1 |
Gisler, RH | 1 |
Brambilla, G | 1 |
Cavanna, M | 1 |
Caraceni, CE | 1 |
Parodi, S | 1 |
Gerchakov, S | 1 |
Schultz, HP | 1 |
el-Asmar, FA | 1 |
Greenberg, DM | 1 |
1 review available for glycine and Leukemia L 1210
Article | Year |
---|---|
Low-molecular-weight immunomodifiers produced by micro-organisms.
Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; | 1985 |
24 other studies available for glycine and Leukemia L 1210
Article | Year |
---|---|
Methotrexate analogues. 16. Importance of the side-chain amide carbonyl group as a structural determinant of biological activity.
Topics: Animals; Binding, Competitive; Cell Survival; Chemical Phenomena; Chemistry; Folic Acid Antagonists; | 1982 |
THE PRIMARY SITE OF INHIBITION BY 6-MERCAPTOPURINE ON THE PURINE BIOSYNTHETIC PATHWAY IN SOME TUMORS IN VIVO.
Topics: Animals; Biosynthetic Pathways; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; DNA, Neop | 1963 |
INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
Topics: Adenine; Animals; Antimetabolites; Antineoplastic Agents; Azaserine; Carcinoma, Squamous Cell; Glyci | 1965 |
Mode of action of 2-amino-6-chloro-1-deazapurine.
Topics: 2-Aminopurine; Adenine; AMP Deaminase; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cel | 1984 |
Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; | 1982 |
Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Topics: Amidohydrolases; Animals; Asparagine; Azo Compounds; Cell Line; Diazooxonorleucine; DNA; Glutamine; | 1981 |
Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
Topics: Animals; Aspartic Acid; Cells, Cultured; Chromatography, High Pressure Liquid; Deoxycytosine Nucleot | 1981 |
Effects of a water-soluble prodrug of vitamin E on doxorubicin-induced toxicity in mice.
Topics: Animals; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Glycine; Leukemia L1210; Lip | 1999 |
Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Topics: 3-Deazauridine; Animals; Antibiotics, Antineoplastic; Drug Resistance; Female; Glycine; Isoxazoles; | 1979 |
Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Topics: Acinetobacter; Amino Acids; Animals; Asparaginase; Carcinoma, Ehrlich Tumor; Drug Synergism; Drug Th | 1979 |
Modulation of cysteine metabolism in mice--effects of propargylglycine and L-cyst(e)ine-degrading enzymes.
Topics: Alkynes; Animals; Cystathionine gamma-Lyase; Cysteine; Diet; Enterobacter; Glycine; Half-Life; In Vi | 1978 |
Studies of the biochemical pharmacology of the fermentation-derived antitumor agent, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cell Line; Cell Survival; Female; Glutamine; Gl | 1978 |
Potentiation by guanine nucleosides of the growth-inhibitory effects of adenosine analogs on L1210 and sarcoma 180 cells in culture.
Topics: Animals; Cell Division; Cells, Cultured; Deoxyribonucleosides; Dose-Response Relationship, Drug; Dru | 1976 |
Protein cross-linking properties of the antitumor agent inosine dialdehyde (NSC-118994).
Topics: Aldehydes; Animals; Cytotoxicity Tests, Immunologic; Drug Interactions; Glycine; Histidine; Humans; | 1976 |
Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Fluorouracil; Glycine; Leukemia L | 1992 |
A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.
Topics: Animals; Cell Division; Cell Line; DNA Replication; DNA, Neoplasm; gamma-Glutamyl Hydrolase; Glycine | 1989 |
[Enhancement of immune response by an antitumor agent, cyclophosphamide].
Topics: Animals; Cell Line; Cyclophosphamide; Female; Fibrosarcoma; Glycine; Immunity, Cellular; Leukemia L1 | 1986 |
Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Female; Glycine; Histocompatibility An | 1986 |
Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Cell Division; Combined Modality Therapy; Cyc | 1985 |
Studies with a mathematical model of folate metabolism.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Floxuridine; Folic Acid; Formates; Glyci | 1973 |
Distribution and metabolism of the periodate oxidation product of 9-beta-D-ribosyl-6-methylthiopurine.
Topics: Animals; Carbon Isotopes; Cell Line; Culture Techniques; Female; Glycine; Leukemia L1210; Male; Mice | 1969 |
[Preliminary studies of the evaluation of immunodepressive activity in L1210 leukemia allografts in mice].
Topics: Amides; Animals; Azathioprine; Azo Compounds; Busulfan; Cyclophosphamide; Glycine; Immunosuppressive | 1970 |
Quinoxaline studies. XIV. Potential anticancer agents. Some quinoxaline amino acid and dipeptide derivatives related to quinoxaline antibiotics.
Topics: Alanine; Amino Acids; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Dipeptides; Gly | 1969 |
Studies on the mechanism of inhibition of tumor growth by the enzyme glutaminase.
Topics: Amidohydrolases; Animals; Azaguanine; Azaserine; Glutaminase; Glycine; Leukemia L1210; Ligases; Lymp | 1966 |